Tacrolimus Therapy
Tacrolimus Therapy is a pharmacological treatment modality within calcineurin inhibitor therapy that specifically employs tacrolimus, a potent immunosuppressive agent, to selectively inhibit calcineurin-mediated T-cell activation for the prevention of organ transplant rejection.
3K
Publications
138.3K
Citations
15K
Authors
2.7K
Institutions
Publications per year
2017–2026
592
3K
Francesco Paolo Schena, M.D. Pascoe, Josefina Alberú et al. · Transplantation · 2009 · 576 citations
A Short-Term Trial of Tacrolimus Ointment for Atopic Dermatitis
Thomas Ruzicka, Thomas Bieber, Erwin Schöpf et al. · New England Journal of Medicine · 1997 · 524 citations · Full text
Medicine, Dermatology, Immunology +16
1–5 of 3K
15K
30
h-index
24
h-index
23
h-index
22
h-index
22
h-index
1–5 of 15K
2.7K
University of Pittsburgh
Pittsburgh, United States
43 h-index
490 publications
35.3K citations
University of Pittsburgh Medical Center
Pittsburgh, United States
37 h-index
281 publications
25.9K citations
KU Leuven
Leuven, Belgium
36 h-index
166 publications
11K citations
Charité - Universitätsmedizin Berlin
Berlin, Germany
35 h-index
175 publications
9.8K citations
Inserm
Paris, France
32 h-index
237 publications
11.1K citations
Erasmus MC
Rotterdam, The Netherlands
29 h-index
236 publications
11.4K citations
University of Miami
Coral Gables, United States
27 h-index
259 publications
18.6K citations

University of Minnesota
Minneapolis, United States
27 h-index
142 publications
14.2K citations
1–8 of 2.7K
298 publications · 22.6K citations
86
h-index
153 publications · 13.4K citations
73
h-index
295 publications · 7.1K citations
37
h-index
Repository · 126 publications · 5K citations
35
h-index
93 publications · 3.9K citations
34
h-index
1–5